Average Co-Inventor Count = 8.89
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (11 from 3,923 patents)
11 patents:
1. 12365690 - Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyrodine-3-carboxylate as Ca1.2 activators
2. 12122761 - 2-azaspiro[3.4]octane derivatives as M4 agonists
3. 11919911 - Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carboxylate and methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as CAV1.2 activators
4. 11820778 - 2-azaspiro[3.4]octane derivatives as M4 agonists
5. 11548865 - 2-azaspiro[3.4]octane derivatives as M4 agonists
6. 11485742 - 2-azaspiro[3.4]octane derivatives as M4 agonists
7. 11453679 - Methyl 2-methyl-5-oxo-1,4,5,7-tetradhydrofuro[3,4-b]pyridine-3-carboxylate compounds as Ca1.2 activators
8. 10112926 - Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitors
9. 10004732 - Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
10. 9862711 - Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
11. 7994203 - Organic compounds